Cargando…
LC-MS-Based Targeted Metabolomics for FACS-Purified Rare Cells
[Image: see text] Metabolism plays a fundamental role in regulating cellular functions and fate decisions. Liquid chromatography-mass spectrometry (LC-MS)-based targeted metabolomic approaches provide high-resolution insights into the metabolic state of a cell. However, the typical sample size is in...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996616/ https://www.ncbi.nlm.nih.gov/pubmed/36812587 http://dx.doi.org/10.1021/acs.analchem.2c04396 |
_version_ | 1784903084524175360 |
---|---|
author | Schönberger, Katharina Mitterer, Michael Glaser, Katharina Stecher, Manuel Hobitz, Sebastian Schain-Zota, Dominik Schuldes, Konrad Lämmermann, Tim Rambold, Angelika S. Cabezas-Wallscheid, Nina Buescher, Joerg M. |
author_facet | Schönberger, Katharina Mitterer, Michael Glaser, Katharina Stecher, Manuel Hobitz, Sebastian Schain-Zota, Dominik Schuldes, Konrad Lämmermann, Tim Rambold, Angelika S. Cabezas-Wallscheid, Nina Buescher, Joerg M. |
author_sort | Schönberger, Katharina |
collection | PubMed |
description | [Image: see text] Metabolism plays a fundamental role in regulating cellular functions and fate decisions. Liquid chromatography-mass spectrometry (LC-MS)-based targeted metabolomic approaches provide high-resolution insights into the metabolic state of a cell. However, the typical sample size is in the order of 10(5)–10(7) cells and thus not compatible with rare cell populations, especially in the case of a prior flow cytometry-based purification step. Here, we present a comprehensively optimized protocol for targeted metabolomics on rare cell types, such as hematopoietic stem cells and mast cells. Only 5000 cells per sample are required to detect up to 80 metabolites above background. The use of regular-flow liquid chromatography allows for robust data acquisition, and the omission of drying or chemical derivatization avoids potential sources of error. Cell-type-specific differences are preserved while the addition of internal standards, generation of relevant background control samples, and targeted metabolite with quantifiers and qualifiers ensure high data quality. This protocol could help numerous studies to gain thorough insights into cellular metabolic profiles and simultaneously reduce the number of laboratory animals and the time-consuming and costly experiments associated with rare cell-type purification. |
format | Online Article Text |
id | pubmed-9996616 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-99966162023-03-10 LC-MS-Based Targeted Metabolomics for FACS-Purified Rare Cells Schönberger, Katharina Mitterer, Michael Glaser, Katharina Stecher, Manuel Hobitz, Sebastian Schain-Zota, Dominik Schuldes, Konrad Lämmermann, Tim Rambold, Angelika S. Cabezas-Wallscheid, Nina Buescher, Joerg M. Anal Chem [Image: see text] Metabolism plays a fundamental role in regulating cellular functions and fate decisions. Liquid chromatography-mass spectrometry (LC-MS)-based targeted metabolomic approaches provide high-resolution insights into the metabolic state of a cell. However, the typical sample size is in the order of 10(5)–10(7) cells and thus not compatible with rare cell populations, especially in the case of a prior flow cytometry-based purification step. Here, we present a comprehensively optimized protocol for targeted metabolomics on rare cell types, such as hematopoietic stem cells and mast cells. Only 5000 cells per sample are required to detect up to 80 metabolites above background. The use of regular-flow liquid chromatography allows for robust data acquisition, and the omission of drying or chemical derivatization avoids potential sources of error. Cell-type-specific differences are preserved while the addition of internal standards, generation of relevant background control samples, and targeted metabolite with quantifiers and qualifiers ensure high data quality. This protocol could help numerous studies to gain thorough insights into cellular metabolic profiles and simultaneously reduce the number of laboratory animals and the time-consuming and costly experiments associated with rare cell-type purification. American Chemical Society 2023-02-22 /pmc/articles/PMC9996616/ /pubmed/36812587 http://dx.doi.org/10.1021/acs.analchem.2c04396 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Schönberger, Katharina Mitterer, Michael Glaser, Katharina Stecher, Manuel Hobitz, Sebastian Schain-Zota, Dominik Schuldes, Konrad Lämmermann, Tim Rambold, Angelika S. Cabezas-Wallscheid, Nina Buescher, Joerg M. LC-MS-Based Targeted Metabolomics for FACS-Purified Rare Cells |
title | LC-MS-Based
Targeted Metabolomics for FACS-Purified
Rare Cells |
title_full | LC-MS-Based
Targeted Metabolomics for FACS-Purified
Rare Cells |
title_fullStr | LC-MS-Based
Targeted Metabolomics for FACS-Purified
Rare Cells |
title_full_unstemmed | LC-MS-Based
Targeted Metabolomics for FACS-Purified
Rare Cells |
title_short | LC-MS-Based
Targeted Metabolomics for FACS-Purified
Rare Cells |
title_sort | lc-ms-based
targeted metabolomics for facs-purified
rare cells |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996616/ https://www.ncbi.nlm.nih.gov/pubmed/36812587 http://dx.doi.org/10.1021/acs.analchem.2c04396 |
work_keys_str_mv | AT schonbergerkatharina lcmsbasedtargetedmetabolomicsforfacspurifiedrarecells AT mitterermichael lcmsbasedtargetedmetabolomicsforfacspurifiedrarecells AT glaserkatharina lcmsbasedtargetedmetabolomicsforfacspurifiedrarecells AT stechermanuel lcmsbasedtargetedmetabolomicsforfacspurifiedrarecells AT hobitzsebastian lcmsbasedtargetedmetabolomicsforfacspurifiedrarecells AT schainzotadominik lcmsbasedtargetedmetabolomicsforfacspurifiedrarecells AT schuldeskonrad lcmsbasedtargetedmetabolomicsforfacspurifiedrarecells AT lammermanntim lcmsbasedtargetedmetabolomicsforfacspurifiedrarecells AT ramboldangelikas lcmsbasedtargetedmetabolomicsforfacspurifiedrarecells AT cabezaswallscheidnina lcmsbasedtargetedmetabolomicsforfacspurifiedrarecells AT buescherjoergm lcmsbasedtargetedmetabolomicsforfacspurifiedrarecells |